DAMANTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 22.880
AS - Asia 7.420
EU - Europa 5.632
SA - Sud America 1.319
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 6
Totale 37.434
Nazione #
US - Stati Uniti d'America 22.633
SG - Singapore 3.569
CN - Cina 1.584
UA - Ucraina 1.469
BR - Brasile 1.092
DE - Germania 978
HK - Hong Kong 827
IT - Italia 725
RU - Federazione Russa 589
FI - Finlandia 543
VN - Vietnam 509
SE - Svezia 325
IE - Irlanda 295
GB - Regno Unito 237
TR - Turchia 224
IN - India 205
CA - Canada 145
KR - Corea 99
FR - Francia 94
AR - Argentina 88
IR - Iran 83
BE - Belgio 68
PL - Polonia 57
ZA - Sudafrica 57
MX - Messico 55
EC - Ecuador 48
JP - Giappone 48
AT - Austria 47
BD - Bangladesh 47
NL - Olanda 40
IQ - Iraq 39
ES - Italia 36
PK - Pakistan 29
CZ - Repubblica Ceca 27
ID - Indonesia 27
RO - Romania 22
TG - Togo 22
AE - Emirati Arabi Uniti 21
PY - Paraguay 21
EG - Egitto 20
EU - Europa 19
CO - Colombia 17
CL - Cile 16
MA - Marocco 15
UZ - Uzbekistan 15
UY - Uruguay 14
VE - Venezuela 14
SA - Arabia Saudita 13
IL - Israele 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
KE - Kenya 10
LT - Lituania 10
RS - Serbia 9
BH - Bahrain 7
HU - Ungheria 7
JM - Giamaica 7
NP - Nepal 7
PA - Panama 7
TN - Tunisia 7
XK - ???statistics.table.value.countryCode.XK??? 7
AU - Australia 6
BG - Bulgaria 6
CH - Svizzera 6
HR - Croazia 6
LB - Libano 6
PH - Filippine 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
DK - Danimarca 4
JO - Giordania 4
KZ - Kazakistan 4
LV - Lettonia 4
PE - Perù 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
LI - Liechtenstein 3
LK - Sri Lanka 3
LU - Lussemburgo 3
TH - Thailandia 3
BO - Bolivia 2
BZ - Belize 2
GA - Gabon 2
GF - Guiana Francese 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
Totale 37.407
Città #
Fairfield 2.753
Woodbridge 2.054
Ashburn 2.004
Singapore 1.545
Chandler 1.409
Houston 1.400
Seattle 1.179
Ann Arbor 1.107
Wilmington 1.035
Jacksonville 965
Cambridge 956
Beijing 848
Hong Kong 824
Dearborn 626
Chicago 431
Los Angeles 428
Boardman 391
Udine 317
Dublin 292
Princeton 278
New York 241
Munich 200
Salt Lake City 190
Izmir 186
Ho Chi Minh City 184
Buffalo 167
Dallas 140
Hefei 133
San Diego 132
São Paulo 100
Seoul 94
Ogden 93
Tampa 89
Redmond 88
Redondo Beach 88
Hanoi 84
Elk Grove Village 83
Des Moines 82
Dong Ket 73
Turku 73
Norwalk 69
Brussels 63
Phoenix 62
Sterling 58
Columbus 52
Warsaw 52
Frankfurt am Main 51
Helsinki 47
Mumbai 47
San Mateo 47
Augusta 45
Ottawa 45
Kunming 44
Tokyo 44
Montreal 43
Lancaster 41
Leawood 39
Santa Clara 39
Düsseldorf 36
Johannesburg 36
Rio de Janeiro 36
Nanjing 35
Trieste 35
Belo Horizonte 34
Brooklyn 33
Grafing 33
Stockholm 33
Falls Church 32
Washington 32
Ardabil 31
Miami 31
The Dalles 31
London 30
Nuremberg 30
Denver 29
Orem 29
Poplar 29
Guangzhou 28
Vienna 27
Toronto 26
Atlanta 25
Chennai 24
Boston 23
Brasília 23
Dulles 23
Lomé 22
Mexico City 22
Amsterdam 21
Lauterbourg 21
Monmouth Junction 21
Codroipo 20
Jinan 20
Pittsburgh 20
San Francisco 20
Baghdad 19
Detroit 19
Quito 19
Ankara 18
Curitiba 18
Kansas City 18
Totale 25.362
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.079
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 468
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 326
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 254
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 213
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 204
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 201
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 196
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 196
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 194
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 187
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 186
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 185
Expression of differentiation markers in cultured cells from various thyroid diseases 179
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 179
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 179
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 179
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 178
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 178
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 177
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 175
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 173
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 173
Expression of periostin in human breast cancer 172
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 172
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 171
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 171
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 169
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 169
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 168
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 168
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 164
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 164
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 164
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 163
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 163
Histone post-translational modifications associated to BAALC expression in leukemic cells. 163
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 162
Galectin-3 expression in non-small cell lung carcinoma 161
Nucleophosmin is overexpressed in thyroid tumors 161
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 161
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 160
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 159
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 159
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 159
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 159
A molecular code dictates sequence-specific DNA recognition by homeodomains 158
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 155
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 155
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 154
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 154
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 153
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 152
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 152
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 151
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 150
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 149
Blood-brain barrier dysfunction in disorders of the developing brain 149
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 147
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 146
null 146
PAX8 expression in human bladder cancer. 145
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 145
A differential proteomic approach to identify proteins associated with thyroid cell transformation 145
Homology model building of the thyroid transcription factor 1 homeodomain 144
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy 144
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 143
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 143
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 143
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 142
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 142
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 142
Molecular events in the differentiation of the thyroid gland 142
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 142
Thyroid-specific gene expression. 141
TSH controls ref-1 nuclear translocation in thyroid cells 141
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 141
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 141
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 140
A CGH array procedure to detect PAX6 gene structural defects 140
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 139
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 139
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 139
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 139
Levels of histone acetylation in thyroid tumors 138
Unexpected phenotype of a typical NPM1 mutant 138
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 138
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 138
Differential proteomic analysis of nuclear extracts from thyroid cell lines 138
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 138
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 136
Effect of thyrotropin and cAMP on FRTL5 cell growth in a serum free medium 136
null 136
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 136
Thyroid defects due to Pax8 gene mutations 134
Regulation of pituitary adenylate cyclase-activating polypeptide gene transcription by TTF-1, a homeodomain-containing transcription factor 134
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 133
Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: Evidence for an autoregulatory loop 133
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 132
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS 132
Totale 17.144
Categoria #
all - tutte 137.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.693 0 0 0 0 0 513 198 436 498 185 611 252
2021/20222.679 169 222 80 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/20267.962 1.362 2.339 996 1.272 1.789 204 0 0 0 0 0 0
Totale 38.018